Allogene Therapeutics (ALLO)
(Real Time Quote from BATS)
$2.62 USD
-0.05 (-1.87%)
Updated Sep 24, 2024 12:46 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.34 | -9.09% |
Earnings Summary
For their last quarter, Allogene Therapeutics (ALLO) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 8.57%. Look out for ALLO's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.34 per share, reflecting a year-over-year increase of 8.11%.
Earnings History
Price & Consensus
Zacks News for ALLO
Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue?
ALLO: What are Zacks experts saying now?
Zacks Private Portfolio Services